MLYS
Price
$34.77
Change
+$1.65 (+4.98%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
2.7B
66 days until earnings call
MNKD
Price
$5.54
Change
+$0.21 (+3.93%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
1.7B
66 days until earnings call
Interact to see
Advertisement

MLYS vs MNKD

Header iconMLYS vs MNKD Comparison
Open Charts MLYS vs MNKDBanner chart's image
Mineralys Therapeutics
Price$34.77
Change+$1.65 (+4.98%)
Volume$74.25K
Capitalization2.7B
MannKind
Price$5.54
Change+$0.21 (+3.93%)
Volume$80.22K
Capitalization1.7B
MLYS vs MNKD Comparison Chart in %
Loading...
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MLYS vs. MNKD commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLYS is a Buy and MNKD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (MLYS: $33.12 vs. MNKD: $5.34)
Brand notoriety: MLYS and MNKD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLYS: 312% vs. MNKD: 142%
Market capitalization -- MLYS: $2.7B vs. MNKD: $1.7B
MLYS [@Biotechnology] is valued at $2.7B. MNKD’s [@Biotechnology] market capitalization is $1.7B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLYS’s FA Score shows that 0 FA rating(s) are green whileMNKD’s FA Score has 0 green FA rating(s).

  • MLYS’s FA Score: 0 green, 5 red.
  • MNKD’s FA Score: 0 green, 5 red.
According to our system of comparison, MNKD is a better buy in the long-term than MLYS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLYS’s TA Score shows that 5 TA indicator(s) are bullish while MNKD’s TA Score has 6 bullish TA indicator(s).

  • MLYS’s TA Score: 5 bullish, 4 bearish.
  • MNKD’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, MNKD is a better buy in the short-term than MLYS.

Price Growth

MLYS (@Biotechnology) experienced а +117.61% price change this week, while MNKD (@Biotechnology) price change was +18.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.44%. For the same industry, the average monthly price growth was +9.94%, and the average quarterly price growth was +31.78%.

Reported Earning Dates

MLYS is expected to report earnings on Nov 11, 2025.

MNKD is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+2.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLYS($2.7B) has a higher market cap than MNKD($1.7B). MLYS YTD gains are higher at: 169.050 vs. MNKD (-16.952). MNKD has higher annual earnings (EBITDA): 79.1M vs. MLYS (-203.01M). MLYS has more cash in the bank: 325M vs. MNKD (179M). MNKD has higher revenues than MLYS: MNKD (302M) vs MLYS (0).
MLYSMNKDMLYS / MNKD
Capitalization2.7B1.7B159%
EBITDA-203.01M79.1M-257%
Gain YTD169.050-16.952-997%
P/E RatioN/A50.36-
Revenue0302M-
Total Cash325M179M182%
Total DebtN/A46.8M-
FUNDAMENTALS RATINGS
MNKD: Fundamental Ratings
MNKD
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
47
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MLYSMNKD
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
70%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WEMCX6.080.08
+1.33%
Allspring Emerging Growth C
SUFCX39.870.46
+1.17%
NAA Mid Growth C
INTIX13.170.11
+0.84%
Voya International Index Port S
MINHX44.260.26
+0.59%
MFS International Intrinsic Value R4
GAOFX21.900.11
+0.50%
JPMorgan Global Allocation R4

MLYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLYS has been loosely correlated with CYTK. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if MLYS jumps, then CYTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLYS
1D Price
Change %
MLYS100%
+13.23%
CYTK - MLYS
54%
Loosely correlated
-0.48%
IONS - MLYS
49%
Loosely correlated
-1.88%
BIESF - MLYS
45%
Loosely correlated
N/A
PTGX - MLYS
39%
Loosely correlated
+2.56%
MNKD - MLYS
38%
Loosely correlated
-3.09%
More

MNKD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MNKD has been loosely correlated with CYTK. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if MNKD jumps, then CYTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNKD
1D Price
Change %
MNKD100%
-3.09%
CYTK - MNKD
46%
Loosely correlated
-0.48%
INSM - MNKD
40%
Loosely correlated
-0.68%
UTHR - MNKD
39%
Loosely correlated
-2.80%
MLYS - MNKD
38%
Loosely correlated
+13.23%
DAWN - MNKD
37%
Loosely correlated
-0.94%
More